A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Clinical trial NCT07100119 · RECRUITING
Trial details
- NCT number
- NCT07100119
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-05
- Primary completion
- 2027-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.